0
Skip to Content
Aqualung Therapeutics, Corp
Home
Science
ALT-100
Pipeline
About US
Management
Scientific Advisory Board
Board of Directors
Resources
ROADMAP
News & Press Releases
Publications
Contact Us
Aqualung Therapeutics, Corp
Home
Science
ALT-100
Pipeline
About US
Management
Scientific Advisory Board
Board of Directors
Resources
ROADMAP
News & Press Releases
Publications
Contact Us
Home
Folder: Science
Back
ALT-100
Pipeline
Folder: About US
Back
Management
Scientific Advisory Board
Board of Directors
Folder: Resources
Back
ROADMAP
News & Press Releases
Publications
Contact Us
KEY ACTIVITIES & PRESS Rebecca Nunn 2/15/21 KEY ACTIVITIES & PRESS Rebecca Nunn 2/15/21

Studies: eNAMPT, an inflammation-regulatory protein is now tightly linked to COVID-19 deaths

Studies: eNAMPT, an inflammation-regulatory protein is now tightly linked to COVID-19 deaths LINK TO FULL ARTICLE 2.13.21 Studies: eNAMPT, an inflammation-regulatory protein is now tightly

Read More
KEY ACTIVITIES & PRESS Rebecca Nunn 2/11/21 KEY ACTIVITIES & PRESS Rebecca Nunn 2/11/21

eNAMPT, the Inflammation-Regulatory Protein Specifically Targeted by Aqualung Therapeutic’s Monoclonal Antibody ALT-100, is now Tightly Linked to Outcomes in COVID-19 Infected Patients

eNAMPT, the Inflammation-Regulatory Protein Specifically Targeted by Aqualung Therapeutic’s Monoclonal Antibody ALT-100, is now Tightly Linked to Outcomes in COVID-19 Infected Patients LINK TO PRESS

Read More
RECENT ARTICLES & PUBLICATIONS Rebecca Nunn 12/2/20 RECENT ARTICLES & PUBLICATIONS Rebecca Nunn 12/2/20

Dr. Joe GN Garcia speaks on the impacts of COVID-19 in the year 2020 in PharmaVOICE Magazine Nov/Dec Issue

Dr. Joe GN Garcia speaks on the impacts of COVID-19 in the year 2020 in PharmaVOICE Magazine

Read More

OFFICE

Mailing Address
6080 N Pinchot Rd
Tucson, Az 85750

450 Ocean Drive, 1205
Juno Beach, FL 33408

CONTACT

Email: info@aqualungtherapeutics.com
Tel: 312-618-7337 or
919-410-0504